CLGM
EVH icon

Capitolis Liquid Global Markets’s Evolent Health EVH Stock Holding History

Capitolis Liquid Global Markets’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Hold
630,000
– – 0.01% 276
2026
Q1 		$1.44M Hold
630,000
– – 0.01% 312
2025
Q4 		$2.52M Hold
630,000
– – 0.02% 266
2025
Q3 		$5.33M Buy
630,000
+6,500
+1% +$63.1K 0.04% 182
2025
Q2 		$7.02M Buy
+623,500
New +$5.73M 0.05% 171

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capitolis Liquid Global Markets's EVH Position: Q2 2026 in Review

Capitolis Liquid Global Markets held its Evolent Health (EVH) position steady in Q2 2026 at 630,000 shares worth $3.41M. The position accounts for 0.01% of the portfolio, ranked #276.

Capitolis Liquid Global Markets first reported a position in EVH in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.02M in Q2 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Capitolis Liquid Global Markets held 630,000 shares of Evolent Health worth $3.41M as of Q2 2026.
  • Capitolis Liquid Global Markets left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 0.01% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #276 holding.
  • Capitolis Liquid Global Markets first reported a position in Evolent Health in Q2 2025 and has held it in 5 quarters since.
  • Capitolis Liquid Global Markets's Evolent Health position peaked at $7.02M in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.